Results 11 to 20 of about 36,244 (312)

Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications, Efficacy, and Adverse Effects of Inactivated Whole-Virus COVID-19 Vaccines Sinopharm, CoronaVac, and Covaxin: An Observational Study

Vaccines, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging viral zoonotic illness that has developed a distinctive and threatening situation globally. Worldwide, many vaccines were introduced to fight against the COVID-19 pandemic.
Sultan Ayoub Meo, Riham A. ElToukhy, Anusha Sultan Meo, David C. Klonoff   +3 more
doaj   +3 more sources

Unexpected hypereosinophilia after Sinopharm vaccination: a case report

BMC Infectious Diseases
Background COVID-19 vaccines have been pivotal in the management of the recent pandemic. However, despite their safety and efficacy, apprehension regarding possible adverse effects has always been raised. Most of the vaccine-related side effects are mild.
Niloofar Khoshnam Rad, Behnam Dalfardi, Maryam Edalatifard, Besharat Rahimi, Sanaz Asadi, Tayebe Mohammad Alizade   +5 more
core   +5 more sources

Perinatal outcomes and sinopharm BBIBP-CorV vaccination during pregnancy

BMC Pregnancy and Childbirth
Abstract Background After the outbreak of COVID-19, a huge part of the health care services was dedicated to preventing and treating this disease. In case of COVID-19 infection, severe COVID-19 is reported more in pregnant individuals.
Donya Hatami, Abbas Habibelahi, Nasrin Changizi, Mohammad Heidarzadeh, Marzieh Nojomi, Moein Rast, Kiarash Ansari, Arash Tehrani‐Banihashemi   +7 more
openaire   +4 more sources

Sinopharm BBIBP-CorVi and Myocarditis: A Causal Link?

Integrative Journal of Medical Sciences, 2022
Since the introduction of the SARS-CoV-2 vaccine, several side effects have been reported, including acute myocarditis, which is primarily associated with mRNA vaccines. However, the cardiac side effects of other forms of vaccination against COVID-19 are
Motiaa, Youssef, Elkhadi, Abdelhak, Aabdi, Mohammed, Sbai, Hicham, Labib, Smael   +4 more
core   +2 more sources

Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter]

Infection and Drug Resistance, 2021
Syed Hasan Shuja,1 Dayab Asad,2 Abdul Samad Parekh3 1Dow Medical College, Karachi, Sindh, Pakistan; 2Jinnah Sindh Medical University, Karachi, Sindh, Pakistan; 3Shaheed Mohtarma Benazir Bhutto Medical College, Karachi, Sindh, PakistanCorrespondence: Syed
Shuja SH, Asad D, Parekh AS
doaj   +4 more sources

Cord blood antibodies following BBIBP‐CorV (Sinopharm) vaccination during pregnancy

Immunity, Inflammation and Disease, 2023
Objective This study aimed to evaluate the maternal and umbilical cord blood antibody levels, after COVID vaccination during pregnancy. Method The women who received the COVID‐19 vaccine (Sinopharm) during pregnancy were included. Maternal and cord blood
Mohammadreza Salehi, Mohammad Mehdi Hasheminejad, Sarang Younesi, Saeedeh Shirdel, Marjan Ghaemi, Pegah Rashidian, Nasim Eshraghi, Fatemeh Asadi, Sedigheh Hantoushzadeh, Nima Rezaei   +9 more
core   +4 more sources

Transient loss of consciousness without cerebral origin following injection of Sinopharm vaccine [PDF]

Journal of Preventive and Complementary Medicine
Background: The Sinopharm vaccine has been widely administered in Iran during COVID-19 pandemic. Clinical trials have identified several side effects associated with the Sinopharm vaccine, including pain at the injection site, fatigue, headache, and ...
Bakhtiar Ebrahimirad, Hero Payandeh
doaj   +2 more sources

Follow-up of Patients With Multiple Sclerosis After COVID-19 Vaccination With Sinopharm Vaccine [PDF]

Caspian Journal of Neurological Sciences, 2023
Background: Vaccination against COVID-19 for people with multiple sclerosis (PWMS) has been recommended, but long-term follow-up needs further research.
Nazanin Razazian, Mohammad-Ali Sahraian, Sharareh Eskandarieh, Nooshin Jafari, Mansour Rezaei, Negin Fakhri   +5 more
doaj   +1 more source

Evaluation of BBIBP-CorV Sinopharm COVID-19 vaccine effectiveness in Sri Lanka: a test-negative case control study

BMJ Open
Objectives There is limited research on real-world effectiveness of BBIBP-CorV Sinopharm COVID-19 vaccine. This study evaluated real-world effectiveness of Sinopharm vaccine in Sri Lanka by assessing absolute vaccine efficacy.Design and setting A ...
Gayan Bogoda, Shamila Thivanshi De Silva, Kanchana Rathnayake, Manjula Kariyawasam, Wathsala Wimalasena, Sumudu Senaratne, Ranjan Premaratna, Gihan Kosinna, Dileepa Senajith Ediriweera, Inosha Weerarathna, Prasanna Gunasena   +10 more
core   +2 more sources

Safety of Sinopharm vaccine for people with Multiple Sclerosis: Study of adverse reactions and disease activity

Multiple Sclerosis and Related Disorders, 2022
Background: The aim of this study was to evaluate the safety of Sinofarm vaccine (BBIBP-CorV) in patients with multiple sclerosis (pwMS). Methods: This study was conducted on pwMS patients in Isfahan, Iran.
Fereshteh Ashtari, Sina Arabi, Aryan Kavosh, Mazaheri, S., Shahbanoo Mazaheri, Iman Adibi, Vahid Shaygannejad, Ashtari, F., Karimi, Z., Saba Naghavi, Maryam Rahimi, Zahra Karimi, Naghavi, S., Rahimi, M., Adibi, I., Kavosh, A., Shaygannejad, V., Arabi, S.   +17 more
core   +3 more sources